Trial Profile
A retrospective study to evaluate the effect of Natalizumab treatment on disease severity in multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 21 Nov 2016 New trial record